AYTU BIOPHARMA, INC Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2019-10-31: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Series F Convertible Preferred Stock and Common Stock Purchase Warrants; Date of first sale 2019-10-16; Total offering amount $10,000,000.
- 2017-08-24: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2017-08-15; Total offering amount $11,839,995.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2019-10-31 | Rule 506(b) | Equity; OptionToAcquire; Series F Convertible Preferred Stock and Common Stock Purchase Warrants | 2019-10-16 | $10,000,000 | $10,000,000 | $0 | 2 |
|---|
| 2017-08-24 | Rule 506(b) | Equity; OptionToAcquire | 2017-08-15 | $11,839,995 | $11,839,995 | $0 | 70 |
|---|